The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

At the end of the March quarter, BC Investments IV Ltd., the Bain Capital entity, held 8.68% stake in the company.

Global investment firm Bain Capital on Friday divested a 2.4 per cent stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction. Following the stake sale, shares of Emcure ...

Get the detailed quarterly/annual income statement for EMCURE PHARMACEUTICALS L (EMCURE.NS). Find out the revenue, expenses and profit or loss over the last fiscal year.

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.